Stephen M. Schreibman

Capecitabine and temozolomide (CAPTEM) for metastatic, well-differentiated neuroendocrine cancers: The Pancreas Center at Columbia University experience

Robert L. Fine, Anthony P. Gulati, Benjamin A. Krantz et al. · Cancer Chemotherapy and Pharmacology · 2013 · 257 citations

Medicine, Oncology, Pharmacology +16

The gemcitabine, docetaxel, and capecitabine (GTX) regimen for metastatic pancreatic cancer: a retrospective analysis

Robert L. Fine, David R. Fogelman, Stephen M. Schreibman et al. · Cancer Chemotherapy and Pharmacology · 2007 · 96 citations

Medicine, Oncology, Pharmacology +14

Effective treatment of neuroendocrine tumors With temozolomide and capecitabine

Robert L. Fine, David R. Fogelman, Stephen M. Schreibman · Journal of Clinical Oncology · 2005 · 58 citations

Medicine, Pharmacology, Endocrine Oncology +1

Management Of Priapism In Patients With Chronic Granulocytic Leukemia

Stephen M. Schreibman, Harry Grabstald · The Journal of Urology · 1974 · 34 citations

Medicine, Hematology, Oncology +6

Phase II trial of GTX chemotherapy in metastatic pancreatic cancer

Robert L. Fine, G. Moorer, William H. Sherman et al. · Journal of Clinical Oncology · 2009 · 17 citations

Medicine, Oncology, Pharmacology +16